Robert C. Duguid
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Robert C. Duguid has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- Archana Koirala
National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, Westmead, New South Wales, Australia
3 shared publications - Ella M. Meumann
Microbiology Department, Territory Pathology, Royal Darwin Hospital
3 shared publications - Pamela Palasanthiran
Department of Infectious Diseases, Sydney Children’s Hospital , Sydney
3 shared publications - Phoebe Catherine May Williams
Department of Infectious Diseases, Sydney Children’s Hospital , Sydney
3 shared publications Priyali Wijeratne
Department of Infectious Diseases, Sydney Children's Hospital , Randwick, NSW
3 shared publications- Adam William Bartlett
Kirby Institute, University of New South Wales, Sydney, Australia
2 shared publications
Latest Publications
- Open Access
- 12 August 2026
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 64 (8) , e0081826
Reply to Gupta, “Reconsidering throat swab culture in melioidosis: diagnostic stewardship with clinical nuance”
- 12 August 2026
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 64 (8) , e0081826
Open AccessReply to Gupta, “Reconsidering throat swab culture in melioidosis: diagnostic stewardship with clinical nuance”
- 28 July 2026
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 45 (10) , e416-e419
Pediatric Melioidosis
Was not provided for this article.
- 28 July 2026
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 45 (10) , e416-e419
Pediatric Melioidosis
Was not provided for this article.
- Open Access
- 10 June 2026
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 64 (6) , e0011326
Throat and rectal swabs to diagnose melioidosis: utility or futility?
- 10 June 2026
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 64 (6) , e0011326
Open AccessThroat and rectal swabs to diagnose melioidosis: utility or futility?
- Open Access
- 2 June 2026
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 13 (6) , ofag275
The Evolving Epidemiology of Invasive Pneumococcal Disease in Australian Children: A Multicentre Retrospective Observational Study
Background: In Australia, high pneumococcal conjugate vaccine (PCV) coverage has been achieved, yet invasive pneumococcal disease (IPD) continues to cause a significant burden of disease. The epidemiology of IPD was altered by the nonpharmaceutical interventions (NPIs) used to control the coronavirus disease (COVID-19) pandemic. We aimed to analyze this impact on the clinical characteristics associated with IPD in Australian children. Method: We systematically evaluated the clinical and microbiological characteristics of IPD in children (14 days; 13% vs 1%, P = .001). Conclusions: Alternations in the prevalence of respiratory viral transmission influence the epidemiology and clinical presentation of IPD. Newer PCVs and the implementation of immunization programs that target viral pathogens associated with IPD may reduce the ongoing burden of IPD in children.
- 2 June 2026
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 13 (6) , ofag275
Open AccessThe Evolving Epidemiology of Invasive Pneumococcal Disease in Australian Children: A Multicentre Retrospective Observational Study
Background: In Australia, high pneumococcal conjugate vaccine (PCV) coverage has been achieved, yet invasive pneumococcal disease (IPD) continues to cause a significant burden of disease. The epidemiology of IPD was altered by the nonpharmaceutical interventions (NPIs) used to control the coronavirus disease (COVID-19) pandemic. We aimed to analyze this impact on the clinical characteristics associated with IPD in Australian children. Method: We systematically evaluated the clinical and microbiological characteristics of IPD in children (14 days; 13% vs 1%, P = .001). Conclusions: Alternations in the prevalence of respiratory viral transmission influence the epidemiology and clinical presentation of IPD. Newer PCVs and the implementation of immunization programs that target viral pathogens associated with IPD may reduce the ongoing burden of IPD in children.
- Open Access
- 1 January 2025
- Published by BMJ in BMJ Public Health
- Vol. 3 (1) , e001312
Antimicrobial resistance among children in Southeast Asia: a systematic review
Introduction: There is increasing evidence that antimicrobial resistance (AMR) is responsible for a large burden of morbidity and mortality in children, potentially compounded by reduced efficacy of many commonly recommended empirical antibiotic regimens to treat infections in children. Methods: We used the PRISMA framework to systematically review studies describing AMR in children (0 to 18 years) in Southeast Asia. We analysed bacterial pathogens with a focus on the Global Antimicrobial Resistance Surveillance System (GLASS) reported in studies published between 2010 and 2023. For each pathogen, non-susceptibility to currently recommended WHO empirical antibiotics was analysed with descriptive statistics. Results: We evaluated AMR profiles for 21 191 bacterial isolates collated across 111 studies incorporating 484 540 children. Most published data (71 studies) arose from India. High levels of non-susceptibility were evident in gram-negative pathogens, with Klebsiella spp. exhibiting particularly high levels of resistance to gentamicin (median: 64%; IQR 38 to 81, n=2097) and third-generation cephalosporins (median 76%; IQR 40 to 92, n=2415). Furthermore, a median of 73% (IQR 50 to 86, n=4405) of Escherichia coli isolates were non-susceptible to third-generation cephalosporins, and 48% (IQR 32 to 64, n=3659) were non-susceptible to gentamicin. Among gram-positive pathogens, the median methicillin resistance to Staphylococcus aureus was 43% (IQR 33 to 60, n=1139). Conclusions: There are very high rates of AMR in pathogens isolated from children with common infectious illnesses in Southeast Asia. However, published data available are of variable quality and are heavily weighted towards South Asian countries (India, Nepal and Bangladesh), limiting the generalisability of these findings and highlighting the need for enhanced clinical surveillance networks to improve the surveillance within this populous and high-burden region. PROSPERO registration number: CRD42021259320.
- 1 January 2025
- Published by BMJ in BMJ Public Health
- Vol. 3 (1) , e001312
Open AccessAntimicrobial resistance among children in Southeast Asia: a systematic review
Introduction: There is increasing evidence that antimicrobial resistance (AMR) is responsible for a large burden of morbidity and mortality in children, potentially compounded by reduced efficacy of many commonly recommended empirical antibiotic regimens to treat infections in children. Methods: We used the PRISMA framework to systematically review studies describing AMR in children (0 to 18 years) in Southeast Asia. We analysed bacterial pathogens with a focus on the Global Antimicrobial Resistance Surveillance System (GLASS) reported in studies published between 2010 and 2023. For each pathogen, non-susceptibility to currently recommended WHO empirical antibiotics was analysed with descriptive statistics. Results: We evaluated AMR profiles for 21 191 bacterial isolates collated across 111 studies incorporating 484 540 children. Most published data (71 studies) arose from India. High levels of non-susceptibility were evident in gram-negative pathogens, with Klebsiella spp. exhibiting particularly high levels of resistance to gentamicin (median: 64%; IQR 38 to 81, n=2097) and third-generation cephalosporins (median 76%; IQR 40 to 92, n=2415). Furthermore, a median of 73% (IQR 50 to 86, n=4405) of Escherichia coli isolates were non-susceptible to third-generation cephalosporins, and 48% (IQR 32 to 64, n=3659) were non-susceptible to gentamicin. Among gram-positive pathogens, the median methicillin resistance to Staphylococcus aureus was 43% (IQR 33 to 60, n=1139). Conclusions: There are very high rates of AMR in pathogens isolated from children with common infectious illnesses in Southeast Asia. However, published data available are of variable quality and are heavily weighted towards South Asian countries (India, Nepal and Bangladesh), limiting the generalisability of these findings and highlighting the need for enhanced clinical surveillance networks to improve the surveillance within this populous and high-burden region. PROSPERO registration number: CRD42021259320.
- Open Access
- 31 October 2023
- Published by Elsevier in The Lancet Regional Health - Southeast Asia
- Vol. 22, 100291
Coverage gaps in empiric antibiotic regimens used to treat serious bacterial infections in neonates and children in Southeast Asia and the Pacific
- 31 October 2023
- Published by Elsevier in The Lancet Regional Health - Southeast Asia
- Vol. 22, 100291
Open AccessCoverage gaps in empiric antibiotic regimens used to treat serious bacterial infections in neonates and children in Southeast Asia and the Pacific
- 20 June 2023
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 59 (8) , 998-1001
Legionella longbeachae cervical lymphadenitis in an immunocompetent adolescent
- 20 June 2023
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 59 (8) , 998-1001
Legionella longbeachae cervical lymphadenitis in an immunocompetent adolescent
- 18 May 2023
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 42 (9) , e341-e342
Clinical and Epidemiologic Profile of Invasive Pneumococcal Disease in Australian Children Following the Relaxation of Nonpharmaceutical Interventions Against SARS-COV-2
A global resurgence of invasive pneumococcal disease (IPD) has been noted in children. We provide a detailed clinical and epidemiological analysis of IPD in Australian children following relaxation of nonpharmaceutical interventions against coronavirus disease 2019, revealing significant morbidity and mortality—even in vaccinated children without known predisposing risk factors. Almost half of the IPD cases were caused by serotypes not covered by the 13-valent pneumococcal conjugate vaccine.
- 18 May 2023
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 42 (9) , e341-e342
Clinical and Epidemiologic Profile of Invasive Pneumococcal Disease in Australian Children Following the Relaxation of Nonpharmaceutical Interventions Against SARS-COV-2
A global resurgence of invasive pneumococcal disease (IPD) has been noted in children. We provide a detailed clinical and epidemiological analysis of IPD in Australian children following relaxation of nonpharmaceutical interventions against coronavirus disease 2019, revealing significant morbidity and mortality—even in vaccinated children without known predisposing risk factors. Almost half of the IPD cases were caused by serotypes not covered by the 13-valent pneumococcal conjugate vaccine.